Ying Taur

Ying Taur

Auto-generated profile, based on publicly available information

Ying Taur

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2014 in Nature
Verified
Journal Article
Open access
PDF file
CBCharlie G. Buffie
Charlie G. Buffie
VBVanni Bucci
Vanni Bucci
RSRichard R. Stein
Richard R. Stein
PMPeter T. McKenney
Peter T. McKenney
LLLilan Ling
Lilan Ling
EPEric G. Pamer
Eric G. Pamer
A fraction of the intestinal microbiota as precise as a single bacterial species confers infection resistance by synthesizing Clostridium difficile-inhibiting metabolites from host-derived bile salts. Antibiotic treatment can kill many members of the normal commensal gut microbiota, leaving patients susceptible to intestinal infection. Among infections that can result from antibiotic-mediated commensal flora destruction, Clostridium difficile colitis is one of the most common and difficult to treat. Eric Pamer and colleagues screened the mouse microbiota with a panel of antibiotics and looked for distinct microbiota changes associated with susceptibility to C. difficile. They identified resistance-associated microbiota constituents common to mice and humans, including Clostridium scindens, which they show confers resistance to infection by synthesizing C. difficile-inhibiting metabolites from host-derived bile salts. These findings could point the way towards novel approaches to the treatment and prevention of C. difficile colitis such as replenishment of secondary bile acids or biosynthesis-competent bacteria as adjuncts to faecal microbiota transplants. The gastrointestinal tracts of mammals are colonized by hundreds of microbial species that contribute to health, including colonization resistance against intestinal pathogens1. Many antibiotics destroy intestinal microbial communities and increase susceptibility to intestinal pathogens2. Among these, Clostridium difficile, a major cause of antibiotic-induced diarrhoea, greatly increases morbidity and mortality in hospitalized patients3. Which intestinal bacteria provide resistance to C. difficile infection and their in vivo inhibitory mechanisms remain unclear. Here we correlate loss of specific bacterial taxa with development of infection, by treating mice with different antibiotics that result in distinct microbiota changes and lead to varied susceptibility to C. difficile. Mathematical modelling augmented by analyses of the microbiota of hospitalized patients identifies resistance-associated bacteria common to mice and humans. Using these platforms, we determine that Clostridium scindens, a bile acid 7α-dehydroxylating intestinal bacterium, is associated with resistance to C. difficile infection and, upon administration, enhances resistance to infection in a secondary bile acid dependent fashion. Using a workflow involving mouse models, clinical studies, metagenomic analyses, and mathematical modelling, we identify a probiotic candidate that corrects a clinically relevant microbiome deficiency. These findings have implications for the rational design of targeted antimicrobials as well as microbiome-based diagnostics and therapeutics for individuals at risk of C. difficile infection.

20 June 2012 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
YTYing Taur
Ying Taur
JXJoao B. Xavier
Joao B. Xavier
LLLauren Lipuma
Lauren Lipuma
CÚCarles Úbeda
Carles Úbeda
JGJenna Goldberg
Jenna Goldberg
EPEric G. Pamer
Eric G. Pamer
Background. Bacteremia is a frequent complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). It is unclear whether changes in the intestinal microbiota during allo-HSCT contribute to the development of bacteremia. We examined the microbiota of patients undergoing allo-HSCT, and correlated microbial shifts with the risk of bacteremia. Methods. Fecal specimens were collected longitudinally from 94 patients undergoing allo-HSCT, from before transplant until 35 days after transplant. The intestinal microbiota was characterized by 454 pyrosequencing of the V1-V3 region of bacterial 16S ribosomal RNA genes. Microbial diversity was estimated by grouping sequences into operational taxonomic units and calculating the Shannon diversity index. Phylogenetic classification was obtained using the Ribosomal Database Project classifier. Associations of the microbiota with clinical predictors and outcomes were evaluated. Results. During allo-HSCT, patients developed reduced diversity, with marked shifts in bacterial populations inhabiting the gut. Intestinal domination, defined as occupation of at least 30% of the microbiota by a single predominating bacterial taxon, occurred frequently. Commonly encountered dominating organisms included Enterococcus, Streptococcus, and various Proteobacteria. Enterococcal domination was increased 3-fold by metronidazole administration, whereas domination by Proteobacteria was reduced 10-fold by fluoroquinolone administration. As a predictor of outcomes, enterococcal domination increased the risk of Vancomycin-resistant Enterococcus bacteremia 9-fold, and proteobacterial domination increased the risk of gram-negative rod bacteremia 5-fold. Conclusions. During allo-HSCT, the diversity and stability of the intestinal flora are disrupted, resulting in domination by bacteria associated with subsequent bacteremia. Assessment of fecal microbiota identifies patients at highest risk for bloodstream infection during allo-HCST.

1 December 2010 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CÚCarles Úbeda
Carles Úbeda
YTYing Taur
Ying Taur
RJRobert R. Jenq
Robert R. Jenq
MEMichele J. Equinda
Michele J. Equinda
TSTammy Son
Tammy Son
EPEric Pamer
Eric Pamer
Bloodstream infection by highly antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a growing clinical problem that increasingly defies medical intervention. Identifying patients at high risk for bacterial sepsis remains an important clinical challenge. Recent studies have shown that antibiotics can alter microbial diversity in the intestine. Here, we characterized these effects using 16s rDNA pyrosequencing and demonstrated that antibiotic treatment of mice enabled exogenously administered VRE to efficiently and nearly completely displace the normal microbiota of the small and large intestine. In the clinical setting, we found that intestinal domination by VRE preceded bloodstream infection in patients undergoing allogeneic hematopoietic stem cell transplantation. Our results demonstrate that antibiotics perturb the normal commensal microbiota and set the stage for intestinal domination by bacteria associated with hospital-acquired infections. Thus, high-throughput DNA sequencing of the intestinal microbiota could identify patients at high risk of developing bacterial sepsis.

14 August 2014 in Blood
Verified
Journal Article
Open access
PDF file
YTYing Taur
Ying Taur
RJRobert R. Jenq
Robert R. Jenq
MPMiguel-Angel Perales
Miguel-Angel Perales
ELEric R. Littmann
Eric R. Littmann
SMSejal Morjaria
Sejal Morjaria
EPEric G. Pamer
Eric G. Pamer
Key Points: Intestinal diversity is predictive of mortality in allo-HSCT.

30 April 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RJRobert R. Jenq
Robert R. Jenq
CÚCarles Úbeda
Carles Úbeda
YTYing Taur
Ying Taur
CMClarissa C. Menezes
Clarissa C. Menezes
RKRaya Khanin
Raya Khanin
MBMarcel R.M. van Den Brink
Marcel R.M. van Den Brink
Despite a growing understanding of the link between intestinal inflammation and resident gut microbes, longitudinal studies of human flora before initial onset of intestinal inflammation have not been reported. Here, we demonstrate in murine and human recipients of allogeneic bone marrow transplantation (BMT) that intestinal inflammation secondary to graft-versus-host disease (GVHD) is associated with major shifts in the composition of the intestinal microbiota. The microbiota, in turn, can modulate the severity of intestinal inflammation. In mouse models of GVHD, we observed loss of overall diversity and expansion of Lactobacillales and loss of Clostridiales. Eliminating Lactobacillales from the flora of mice before BMT aggravated GVHD, whereas reintroducing the predominant species of Lactobacillus mediated significant protection against GVHD. We then characterized gut flora of patients during onset of intestinal inflammation caused by GVHD and found patterns mirroring those in mice. We also identified increased microbial chaos early after allogeneic BMT as a potential risk factor for subsequent GVHD. Together, these data demonstrate regulation of flora by intestinal inflammation and suggest that flora manipulation may reduce intestinal inflammation and improve outcomes for allogeneic BMT recipients.

24 June 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ERElizabeth V. Robilotti
Elizabeth V. Robilotti
NBN. Esther Babady
N. Esther Babady
PMPeter A. Mead
Peter A. Mead
TRThierry Rolling
Thierry Rolling
RPRocio Perez-Johnston
Rocio Perez-Johnston
MKMini Kamboj
Mini Kamboj